---
title: ISPOR Europe 2026
description: Klick Health is the world’s largest independent life sciences and full-service commercialization partner. With a foundation in market access strategy bolstered by experts in data analytics, digital transformation, and patient access solutions, we strive to redefine the boundaries of a traditional market access partner—as your transformative ally in navigating healthcare’s complex access landscape.
---

- [Health Klick Health](https://www.klick.com)
- [Consulting Klick Consulting](https://consulting.klick.com)
- Group Klick Group

 Klick  
 Group

The Klick Group of companies is an ecosystem of brilliant minds working to realize the full potential of their people and clients since 1997.

- [Klick Health](https://www.klick.com)
- [Klick Katalyst](https://katalyst.klick.com)
- [Klick Consulting](https://consulting.klick.com)
- [Klick Applied Sciences](https://appliedsciences.klick.com)
- [Klick Media](https://media.klick.com)
- [Klick Transformation](https://transformation.klick.com)
- [Klick Ideas Exchange](https://idx.klick.com)
- [Oxford PharmaGenesis](https://www.pharmagenesis.com)
- [Newsroom](https://www.klick.com/news)
- [Careers @ Klick](https://careers.klick.com)

- [Get in Touch](https://go.klick.com/pharmagenesis-ispor-europe#contact-form)

- [Get in Touch](https://go.klick.com/pharmagenesis-ispor-europe#contact-form)

- <https://www.linkedin.com/company/klick-health>
- <https://twitter.com/klickhealth>
- <https://www.facebook.com/KlickHealth>
- <https://www.instagram.com/klick.health>
- <https://www.youtube.com/KlickHealth>

 © 2026 All rights reserved. Klick Health® is a trademark of Klick Inc.

# ISPOR Europe 2026

# Where Evidence Meets Access Let's Connect in Vienna

ISPOR Europe 2026

# Where Evidence Meets Access Let's Connect in Vienna

![OPG\_LOGO\_KH\_STRAPLINE-WHITE\_KO-1](https://go.klick.com/hs-fs/hubfs/OPG_LOGO_KH_STRAPLINE-WHITE_KO-1.png?width=220&height=99&name=OPG_LOGO_KH_STRAPLINE-WHITE_KO-1.png "OPG_LOGO_KH_STRAPLINE-WHITE_KO-1")

![OPG\_LOGO\_KH\_STRAPLINE-WHITE\_KO-1](https://go.klick.com/hs-fs/hubfs/OPG_LOGO_KH_STRAPLINE-WHITE_KO-1.png?width=200&height=90&name=OPG_LOGO_KH_STRAPLINE-WHITE_KO-1.png "OPG_LOGO_KH_STRAPLINE-WHITE_KO-1")

Key Insights from the Conference

1. Access is both an execution and a pricing challenge. Payers are tightening UM, PA, site-of-care controls, and affordability scrutiny, so brands need stronger pull-through systems, not just sharper access strategy.
2. Direct-to-Patient (DTP) is becoming a serious commercialization pathway, driven by payer friction, high deductibles, LOE pressure, and patient demand for simpler access.
3. AI’s near-term value is in reducing access friction. The strongest use cases are PA automation, benefits verification, workflow orchestration, and patient support optimization, not abstract AI hype.
4. Patient support is shifting from hub enrolment to connected care. Asembia reinforced that first script is not enough; brands need digital plus human support that helps patients start, stay, and persist on therapy.
5. Cost clarity is becoming a commercialization advantage. Upfront Out-of-Pocket visibility and clearer affordability pathways can reduce abandonment and build confidence at the point of prescribing.

Key Insights from the Conference

\- Access is both an execution and a pricing challenge. Payers are tightening UM, PA, site-of-care controls, and affordability scrutiny, so brands need stronger pull-through systems, not just sharper access strategy.

\- Direct-to-Patient (DTP) is becoming a serious commercialization pathway, driven by payer friction, high deductibles, LOE pressure, and patient demand for simpler access.

\- AI’s near-term value is in reducing access friction. The strongest use cases are PA automation, benefits verification, workflow orchestration, and patient support optimization, not abstract AI hype.

\- Patient support is shifting from hub enrolment to connected care. Asembia reinforced that first script is not enough; brands need digital plus human support that helps patients start, stay, and persist on therapy.

\- Cost clarity is becoming a commercialization advantage. Upfront Out-of-Pocket visibility and clearer affordability pathways can reduce abandonment and build confidence at the point of prescribing.

![About the conference - square 1080 x 1080 (3)](https://go.klick.com/hs-fs/hubfs/About%20the%20conference%20-%20square%201080%20x%201080%20(3).png?width=1080&height=1080&name=About%20the%20conference%20-%20square%201080%20x%201080%20(3).png)

Presentation Details

The Shifting Policy Landscape in Healthcare and the Impact on Specialty Pharmacy

The Shifting Policy Landscape in Healthcare and the Impact on Specialty Pharmacy

Date: Wednesday, April 29th  
Time: 9:00AM - 9:40AM PST

Speakers:  
John Guarino, Chairman Emeritus, Market Access  
Adrian Garcia, Managing Director, Market Access  
Curtis Wander, Executive Director, Content Strategy, Market Access

---

Major policy and payer shifts, from PBM reforms to IRA implementation are transforming specialty pharmacy.

This session will explore how regulatory changes, new payer utilization frameworks, and emerging distribution models are impacting specialty pharmacies and manufacturers alike. Attendees will gain practical insights into the risks, opportunities, and strategic responses needed to navigate a more complex and highly regulated access environment.

---

Missed the session? Download the presentation deck below.

## The Shifting Policy Landscape in Healthcare and the Impact on Specialty Pharmacy

Major policy and payer shifts are reshaping specialty pharmacy, from PBM reforms to IRA implementation. Download the presentation to explore how regulatory changes, payer utilization frameworks, and emerging distribution models are impacting specialty pharmacies and manufacturers.

### Download the Deck

Key Insights From the Conference

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur. Excepteur sint occaecat cupidatat non proident, sunt in culpa qui officia deserunt mollit anim id est laborum

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur. Excepteur sint occaecat cupidatat non proident, sunt in culpa qui officia deserunt mollit anim id est laborum

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur. Excepteur sint occaecat cupidatat non proident, sunt in culpa qui officia deserunt mollit anim id est laborum

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur. Excepteur sint occaecat cupidatat non proident, sunt in culpa qui officia deserunt mollit anim id est laborum

# About the Conference

### ISPOR Europe 2026 | Austria Center Vienna

ISPOR Europe 2026 brings together the global HEOR community to explore how evidence, policy, and evolving expectations around value are shaping healthcare access and decision-making.

Oxford PharmaGenesis, part of the Klick Health family, will be in Vienna joining the conversations that are shaping access. We connect clinical, economic, social, policy, and behavioural expertise to address the questions that matter across the lifecycle, from evidence strategy and synthesis to value stories and payer communications.

Heading to Vienna? Come visit us at Booth #1008.

[Let's Connect](https://go.klick.com/pharmagenesis-ispor-europe?hsLang=en#contact-form)

![ABOUT-05](https://go.klick.com/hs-fs/hubfs/ABOUT-05.png?width=1254&height=1254&name=ABOUT-05.png)

# Featured Article

Three ISPOR Europe 2026 posters examine matching AI tools to a literature review’s purpose, covering risk-tiered workflows, generative AI mapping, and in-house specialist models. 

[Read More](https://idx.klick.com/articles/matching-the-ai-to-the-evidence)

![\_thumbnail\_1](https://go.klick.com/hs-fs/hubfs/_thumbnail_1.jpg?width=2000&name=_thumbnail_1.jpg)

# Additional Content

Explore our research which evaluates a range of AI-assisted evidence identification   
and synthesis approaches, delivered with expert human oversight.

An expert-defined framework guides LLM-assisted mapping of abstract-level evidence across multiple topics to identify themes and potential evidence gaps at scale. The approach supports exploratory landscape insight and requires expert review. 

[Access the Poster](https://www.congressposter.com/p/bd3z2sbve8mvl9t7)

![OQPR101a\_ISPOR Poster thumbnails\_v3\_POSTER 1 (1)](https://go.klick.com/hs-fs/hubfs/OQPR101a_ISPOR%20Poster%20thumbnails_v3_POSTER%201%20(1).png?width=2000&name=OQPR101a_ISPOR%20Poster%20thumbnails_v3_POSTER%201%20(1).png)

A proposed risk-based workflow translates converging guidance into practical choices about AI use in systematic literature reviews. It links validation, human oversight, and reporting to the purpose of the evidence, rather than treating every review as the same. 

[Access the Poster](https://www.congressposter.com/p/7robjdffjlovcisv)

![OQPR101a\_ISPOR Poster thumbnails\_v3\_POSTER 2 (1)](https://go.klick.com/hs-fs/hubfs/OQPR101a_ISPOR%20Poster%20thumbnails_v3_POSTER%202%20(1).png?width=2000&name=OQPR101a_ISPOR%20Poster%20thumbnails_v3_POSTER%202%20(1).png)

A supervised biomedical transformer approach uses human-labelled examples with iterative review and refinement to rank abstracts for exploratory literature reviews. The analysis evaluates the relevance of the highest-ranked abstracts rather than complete recall of all relevant literature. 

[Access the Poster](https://www.congressposter.com/p/69wcx2867e3dxmmk)

![OQPR101a\_ISPOR Poster thumbnails\_v3\_POSTER 3 (1)](https://go.klick.com/hs-fs/hubfs/OQPR101a_ISPOR%20Poster%20thumbnails_v3_POSTER%203%20(1).png?width=2000&name=OQPR101a_ISPOR%20Poster%20thumbnails_v3_POSTER%203%20(1).png)

# Let's Connect

Connect with us at the conference and let's discuss how we can elevate your initiatives. Tell us a bit about yourself below, and we'll be in touch shortly.

[There’s something different here.](https://www.klick.com)

## Our offices

APAC+

### Singapore

30 Raffles Pl

Singapore 048622

### Melbourne

Level 3, Suite 343

Two Melbourne Quarter

697 Collins Street, Docklands

Melbourne VIC 3008

Australia

EMEA+

### London

2nd Floor Heron House

15 Adam Street

London WC2N 6RJ

UK

### Oxford

Tubney Warren Barn

Tubney, Oxford OX13 5QJ

UK

### Oxford Central

Chamberlain House

5 St Aldates Courtyard

38 St Aldates

Oxford OX1 1BN

UK

### Cardiff

30 Windsor Place

Cardiff CF10 3BZ

UK

### Cambridge

9 Hills Road

Cambridge CB2 1GE

UK

LATAM+

### São Paulo

Nações Unidas, 14261, Torre B

Vila Gertrudes

São Paulo, SP 04794-000

Brazil

NA+

### Toronto

175 Bloor Street East

Suite 300, North Tower

Toronto, ON M4W 3R8

### New York City

240 W 40th Street

12th Floor

New York, NY 10018

USA

### Philadelphia

510 Walnut Street

13th Floor

Philadelphia, PA 19106-3601

USA

### Saratoga Springs

125 High Rock Avenue

Suite 300

Saratoga Springs, NY 12866

USA

Discover Klick

- [Klick Katalyst](https://katalyst.klick.com)
- [Klick Consulting](https://consulting.klick.com)
- [Klick Media](https://media.klick.com)
- [Klick Applied Sciences](https://appliedsciences.klick.com)
- [Klick Ideas Exchange](https://idx.klick.com)
- [Oxford PharmaGenesis](https://www.pharmagenesis.com/)
- [Careers @ Klick](https://careers.klick.com)
- [Newsroom](https://www.klick.com/news)

- [Contact Us](https://www.klick.com/contact)
- [Newsletter](https://www.klick.com/klickwire)
- [Privacy Notice](https://www.klick.com/privacy)
- [Intellectual Property](https://www.klick.com/intellectualproperty)
- [Global Capabilities](https://www.klick.com/global)
- Cookie Settings
- [Accessibility Statement](https://www.klick.com/accessibility)
- [Do Not Sell Or Share My Personal Information](https://www.klick.com/privacy#ccpa)

Follow us on

- <https://www.linkedin.com/company/klick-health>
- <https://twitter.com/klickhealth>
- <https://www.facebook.com/KlickHealth>
- <https://www.instagram.com/klick.health>
- <https://www.youtube.com/KlickHealth>

© 2026 Klick Inc. All rights reserved. Klick Health and the Klick Health design mark are registered in the U.S. Patent and Trademark Office and are trademarks of Klick Inc.